Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Celanese heads into its November 2 earnings with short sellers slowly retreating, insiders stepping in with their own money, and a stock trading at a fraction of where analysts think it should be.
The most striking fact in this week's data is the insider buying cluster from August. CFO Chuck Kyrish made three open-market purchases on August 14, spending roughly $104,000 at prices around $45.50. SVP and General Counsel Ashley Duffie added 600 shares the same week, and SVP for Acetyls Mark Murray bought over 2,100 shares for roughly $98,000. None of these trades were made under a 10b5-1 plan, making them discretionary. Net insider buying over the 90 days to August 14 came to just over $230,000 across 5,053 shares. The stock closed Friday at $45.02, barely changed from where those insiders were buying two months ago.
Short positioning has been easing, though it remains meaningful. Short interest has fallen roughly 11% over the past month to 5.6% of the free float, with the decline continuing into this week at a pace of about 2.5%. The borrow market is relaxed. Availability has widened dramatically in recent weeks, reaching 2,695% of outstanding short interest, meaning lenders are carrying roughly 27 times the current short position in lendable inventory. That compares to a 52-week low availability of 377%, when the borrow pool was far tighter. Cost to borrow is negligible at 0.51%, eased about 9% on the week. There is no squeeze pressure here, and the lending market signals that bears face no friction in maintaining positions, but the falling short count suggests fewer are bothering.
Options positioning is the mildest part of the story. The put/call ratio of 0.61 is running slightly below its 20-day average of 0.63, a fractionally more bullish lean than usual and well off the 52-week high of 1.64 hit earlier in the year. The z-score of negative 0.41 puts this squarely in neutral territory. Options traders are not hedging aggressively ahead of the November 2 print.
The Street's position is broadly constructive but tinged with caution. Citigroup trimmed its target to $58 from $60 at the end of September while keeping its Buy rating. Keybanc initiated with Overweight at $57 in September. Both Wells Fargo and Morgan Stanley hold positive or neutral ratings but have pulled targets lower over the summer in response to weaker demand data. The mean analyst target stands at $63.24, implying about 40% upside from the current $45.02 level. That gap is as much a reflection of how far the stock has fallen as it is confidence in a recovery. Forward earnings revisions are running in the 80th percentile versus the broader universe, a brighter signal than the 27th to 32nd percentile EPS momentum and surprise scores would suggest. The stock trades at 7.3 times earnings and 8 times EV/EBITDA, offering limited multiple expansion risk in either direction. Price to book is essentially at par.
Institutional ownership adds another layer of stability. Dodge and Cox holds nearly 14% of shares and has been steady. BlackRock added 440,000 shares as of September 30, lifting its position to 12.2%. Norges Bank has been an aggressive builder, adding close to 9 million shares to reach 8.5% as of June. On the 13D/G register, Capital International Investors trimmed from 6.8% to 3.0%, and Vanguard's original block fell to zero before two Vanguard sub-entities each filed fresh 13G positions at around 5% to 5.7% in April. No activist 13D filings are on the register.
Retail attention is running notably high relative to the stock's own recent history. Wikipedia page views for Celanese carry a z-score of 2.1 against the prior 90 days, putting retail curiosity near its highest level of that window.
The last two earnings prints produced negative one-day moves of roughly 1.7% and 2.9%, with the five-day pattern similarly soft. With November 2 three weeks away, the question is whether the combination of falling short interest, executive buying near current prices, and an unusually wide spread between the stock price and analyst targets reflects a turning point in sentiment or simply a sector that has yet to find its floor.
See the live data behind this article on ORTEX.
Open CE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
